Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Ignacio Melero, Eduardo Castañón, Maite Álvarez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 9, pp. 558-576
Open Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

Cancer vaccines: the next immunotherapy frontier
Matthew J. Lin, Judit Svensson‐Arvelund, Gabrielle S. Lubitz, et al.
Nature Cancer (2022) Vol. 3, Iss. 8, pp. 911-926
Closed Access | Times Cited: 547
The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes
Qizhao Huang, Xia Wu, Zhiming Wang, et al.
Cell (2022) Vol. 185, Iss. 22, pp. 4049-4066.e25
Open Access | Times Cited: 224
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 203
Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria
Wenguang Wang, Haiheng Xu, Qingsong Ye, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 1, pp. 44-53
Closed Access | Times Cited: 131
Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 114
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 440-462
Closed Access | Times Cited: 96
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 2, pp. 129-143
Open Access | Times Cited: 95
Biosafety of mesoporous silica nanoparticles; towards clinical translation
Araceli Lérida‐Viso, Alejandra Estepa‐Fernández, Alba García‐Fernández, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115049-115049
Open Access | Times Cited: 94
Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
Nazeer Hasan, Arif Nadaf, Mohammad Imran, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 93
Intravenous Delivery of Living Listeria monocytogenes Elicits Gasdmermin-Dependent Tumor Pyroptosis and Motivates Anti-Tumor Immune Response
Yao Liu, Yiping Lu, Bo Ning, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 4102-4115
Closed Access | Times Cited: 90
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 90
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 60
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 56
Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy
Yuebao Zhang, Xucheng Hou, Shi Du, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 11, pp. 1364-1374
Closed Access | Times Cited: 47
Type I interferon and cancer
Peter Holíček, Emma Guilbaud, Vanessa Klapp, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 115-127
Open Access | Times Cited: 42
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
Angela Q. Zhang, Alexander Hostetler, Laura E. Chen, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1113-1128
Open Access | Times Cited: 41
Tumor‐Tailored Ionizable Lipid Nanoparticles Facilitate IL‐12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy
Shufen Xu, Yue Xu, Nicholas C. Solek, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 23
Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation
Suyog Shaha, Danika Rodrigues, Samir Mitragotri
Journal of Controlled Release (2024) Vol. 367, pp. 737-767
Closed Access | Times Cited: 19
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
Clément Anfray, Francesco Mainini, Elisabeth Digifico, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e002408-e002408
Open Access | Times Cited: 69
Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics
Changrong Shi, Qianyu Zhang, Yuying Yao, et al.
Nature Nanotechnology (2022) Vol. 18, Iss. 1, pp. 86-97
Open Access | Times Cited: 62
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial
Song‐Yang Wu, Ying Xu, Li Chen, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 61
A Microneedle Patch with Self-Oxygenation and Glutathione Depletion for Repeatable Photodynamic Therapy
Yashi Li, Gang He, Lian‐Hua Fu, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 17298-17312
Closed Access | Times Cited: 52
Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
Junmeng Zhu, Yaohua Ke, Qin Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
Shinya Abe, Hiroshi Nagata, Erika J. Crosby, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003717-e003717
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top